Influence of corevalve revalving system implantation on mitral valve function: An Echocardiographic Study in Selected Patients

Benedetta De Chiara, Antonella Moreo, Federico De Marco, Francesco Musca, Jacopo Oreglia, Elisabetta Lobiati, Giuseppe Bruschi, Oriana Belli, Francesco Mauri, Silvio Klugmann

Research output: Contribution to journalArticle


Objectives: The purpose of this study is to verify whether transcatheter aortic valve implantation (TAVI) determined changes in mitral valve (MV) function, in terms of mitral regurgitation (MR) and stenosis. Background: Little data is available regarding the effects of TAVI on global MV function, often derived from analysis primarily focused on clinical and aortic related outcomes. Methods: From May 2008 to March 2010, 73 patients with severe symptomatic aortic stenosis underwent TAVI with the CoreValve ReValving System. The study population consisted of 58 patients (27 males, mean age 82 ± 7 years) who underwent transthoracic echocardiography at least ≥1 month after implantation (mean follow-up 7.8 ± 5.4 months). Results: In patients with a left ventricular dysfunction (ejection fraction, EF,

Original languageEnglish
Pages (from-to)638-644
Number of pages7
JournalCatheterization and Cardiovascular Interventions
Issue number4
Publication statusPublished - Oct 3 2011



  • CoreValve ReValving system
  • implantation depth
  • mitral regurgitation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this